CHRS Change in Working Capital
Coherus Oncology Inc · Change in Working Capital
CHRS Change in Working Capital
Latest reported-$102.26Mperiod ending
CHRS TTM Change in Working Capital ($44.34M → -$102.26M)
TTM change in working capital
High-resolution chart · PNG
CHRS change in working capital history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -102,261,000 | |
| -69,515,000 | |
| -34,975,000 | |
| 32,356,000 | |
| -19,785,000 | |
| 78,131,000 | |
| 55,894,000 | |
| 7,725,000 | |
| 41,635,000 | |
| -38,858,000 | |
| -36,826,000 | |
| -97,808,000 | |
| -61,494,000 | |
| -71,486,000 | |
| -79,257,000 | |
| -45,253,000 | |
| -21,629,000 | |
| 18,851,000 | |
| 42,360,000 | |
| 68,758,001 | |
| 41,869,001 | |
| 2,483,001 | |
| -37,938,999 | |
| -85,874,000 | |
| -94,133,000 | |
| -99,482,000 | |
| -113,928,000 | |
| -66,330,000 | |
| -60,878,000 | |
| -38,733,000 | |
| 10,297,000 | |
| 6,969,000 | |
| 12,221,000 | |
| 3,248,000 | |
| -5,133,000 | |
| -27,551,000 | |
| -188,974,000 | |
| -151,231,000 | |
| -159,214,000 | |
| -88,287,000 | |
| 71,448,000 | |
| 74,134,000 | |
| 91,115,000 | |
| 29,188,000 | |
| 21,040,000 | |
| 4,502,000 | |
| 28,434,000 | |
| 54,803,000 | |
| 83,794,000 | |
| 68,661,000 | |
| 44,337,000 |